Literature DB >> 14759357

Treatment of hypertension and prevention of ischemic stroke.

Wilbert S Aronow1, William H Frishman.   

Abstract

Data clearly indicate that treatment with antihypertensive drugs reduces the incidence of all strokes in men (by 34%), women (by 38%), elderly persons (by 36%), including those older than 80 years (by 34%), younger persons, those with systolic and diastolic hypertension, persons with isolated systolic hypertension, and in those with a history of stroke or transient ischemic attack (by 28%). Blood pressure should be reduced to less than 140/90 mm Hg. The overall data also suggest that reduction of stroke in persons with hypertension is related more to a reduction in blood pressure than to the type of antihypertensive drugs used.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14759357     DOI: 10.1007/s11886-004-0010-2

Source DB:  PubMed          Journal:  Curr Cardiol Rep        ISSN: 1523-3782            Impact factor:   2.931


  31 in total

1.  What is the appropriate treatment of hypertension in elders?

Authors:  Wilbert S Aronow
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2002-08       Impact factor: 6.053

2.  Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients.

Authors:  S Yusuf; P Sleight; J Pogue; J Bosch; R Davies; G Dagenais
Journal:  N Engl J Med       Date:  2000-01-20       Impact factor: 91.245

3.  Randomised double-blind comparison of placebo and active treatment for older patients with isolated systolic hypertension. The Systolic Hypertension in Europe (Syst-Eur) Trial Investigators.

Authors:  J A Staessen; R Fagard; L Thijs; H Celis; G G Arabidze; W H Birkenhäger; C J Bulpitt; P W de Leeuw; C T Dollery; A E Fletcher; F Forette; G Leonetti; C Nachev; E T O'Brien; J Rosenfeld; J L Rodicio; J Tuomilehto; A Zanchetti
Journal:  Lancet       Date:  1997-09-13       Impact factor: 79.321

4.  Effect of antihypertensive drug treatment on cardiovascular outcomes in women and men. A meta-analysis of individual patient data from randomized, controlled trials. The INDANA Investigators.

Authors:  F Gueyffier; F Boutitie; J P Boissel; S Pocock; J Coope; J Cutler; T Ekbom; R Fagard; L Friedman; M Perry; R Prineas; E Schron
Journal:  Ann Intern Med       Date:  1997-05-15       Impact factor: 25.391

5.  Major cardiovascular events in hypertensive patients randomized to doxazosin vs chlorthalidone: the antihypertensive and lipid-lowering treatment to prevent heart attack trial (ALLHAT). ALLHAT Collaborative Research Group.

Authors: 
Journal:  JAMA       Date:  2000-04-19       Impact factor: 56.272

6.  Cardiovascular morbidity and mortality in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol.

Authors:  Björn Dahlöf; Richard B Devereux; Sverre E Kjeldsen; Stevo Julius; Gareth Beevers; Ulf de Faire; Frej Fyhrquist; Hans Ibsen; Krister Kristiansson; Ole Lederballe-Pedersen; Lars H Lindholm; Markku S Nieminen; Per Omvik; Suzanne Oparil; Hans Wedel
Journal:  Lancet       Date:  2002-03-23       Impact factor: 79.321

7.  Cardiovascular morbidity and mortality in patients with diabetes in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol.

Authors:  Lars H Lindholm; Hans Ibsen; Björn Dahlöf; Richard B Devereux; Gareth Beevers; Ulf de Faire; Frej Fyhrquist; Stevo Julius; Sverre E Kjeldsen; Krister Kristiansson; Ole Lederballe-Pedersen; Markku S Nieminen; Per Omvik; Suzanne Oparil; Hans Wedel; Peter Aurup; Jonathan Edelman; Steven Snapinn
Journal:  Lancet       Date:  2002-03-23       Impact factor: 79.321

8.  MRC trial of treatment of mild hypertension: principal results. Medical Research Council Working Party.

Authors: 
Journal:  Br Med J (Clin Res Ed)       Date:  1985-07-13

Review 9.  Hypertension in the elderly. Implications and generalizability of randomized trials.

Authors:  C D Mulrow; J A Cornell; C R Herrera; A Kadri; L Farnett; C Aguilar
Journal:  JAMA       Date:  1994-12-28       Impact factor: 56.272

10.  The relative importance of selected risk factors for various manifestations of cardiovascular disease among men and women from 35 to 64 years old: 30 years of follow-up in the Framingham Study.

Authors:  J Stokes; W B Kannel; P A Wolf; L A Cupples; R B D'Agostino
Journal:  Circulation       Date:  1987-06       Impact factor: 29.690

View more
  9 in total

Review 1.  Treating hypertension in older adults: safety considerations.

Authors:  Wilbert S Aronow
Journal:  Drug Saf       Date:  2009       Impact factor: 5.606

2.  Treatment of systemic hypertension.

Authors:  Wilbert S Aronow
Journal:  Am J Cardiovasc Dis       Date:  2012-07-25

3.  Predicting stroke risk in hypertensive patients with coronary artery disease: a report from the INVEST.

Authors:  Antonio Coca; Franz H Messerli; Athanase Benetos; Qian Zhou; Annette Champion; Rhonda M Cooper-DeHoff; Carl J Pepine
Journal:  Stroke       Date:  2007-12-27       Impact factor: 7.914

4.  Prediction and Subtyping of Hypertension from Pan-Tissue Transcriptomic and Genetic Analyses.

Authors:  Mahashweta Basu; Mahfuza Sharmin; Avinash Das; Nishanth Ulhas Nair; Kun Wang; Joo Sang Lee; Yen-Pei Christy Chang; Eytan Ruppin; Sridhar Hannenhalli
Journal:  Genetics       Date:  2017-09-12       Impact factor: 4.562

Review 5.  Hypertension-related stroke prevention in the elderly.

Authors:  Wilbert S Aronow
Journal:  Curr Hypertens Rep       Date:  2013-12       Impact factor: 5.369

6.  Diagnosis, treatment, and referral of hypertension or prehypertension in an emergency department after an educational program: preliminary results.

Authors:  Tushar Shah; Wilbert S Aronow; Stephen J Peterson; David Goldwag
Journal:  J Clin Hypertens (Greenwich)       Date:  2011-01-31       Impact factor: 3.738

7.  2013 Korean Society of Hypertension guidelines for the management of hypertension: part III-hypertension in special situations.

Authors:  Jinho Shin; Jeong Bae Park; Kwang-Il Kim; Ju Han Kim; Dong Heon Yang; Wook Bum Pyun; Young Gweon Kim; Gheun-Ho Kim; Shung Chull Chae
Journal:  Clin Hypertens       Date:  2015-04-15

8.  Cost-effectiveness analysis of integrating screening and treatment of selected non-communicable diseases into HIV/AIDS treatment in Uganda.

Authors:  David Sando; Alexander Kintu; Samson Okello; Peter Chris Kawungezi; David Guwatudde; Gerald Mutungi; Winnie Muyindike; Nicolas A Menzies; Goodarz Danaei; Stéphane Verguet
Journal:  J Int AIDS Soc       Date:  2020-06       Impact factor: 6.707

9.  2018 Korean society of hypertension guidelines for the management of hypertension: part III-hypertension in special situations.

Authors:  Kwang-Il Kim; Sang-Hyun Ihm; Gheun-Ho Kim; Hyeon Chang Kim; Ju Han Kim; Hae-Young Lee; Jang Hoon Lee; Jong-Moo Park; Sungha Park; Wook Bum Pyun; Jinho Shin; Shung Chull Chae
Journal:  Clin Hypertens       Date:  2019-08-01
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.